Walgreens Boots Alliance Price Target Update
Recently, analysts at TD Cowen revised their outlook for Walgreens Boots Alliance (NASDAQ: WBA), lowering the price target from $16 to $14 while maintaining a Buy rating on the stock. This adjustment follows a thorough review of the company's fourth fiscal quarter performance and updated projections for FY25.
Adjustments to Earnings Estimates
The firm has adjusted its earnings per share (EPS) estimates for fiscal year 2025, now predicting it to be $1.54 compared to the earlier forecast of $1.71. The reevaluation included a comprehensive analysis of how store closures might impact the company's financial health.
Despite this downward adjustment for FY25, analysts anticipate a slower decline in adjusted EPS for fiscal year 2026, followed by the prospect of renewed growth in FY27. This positive outlook reflects a longer-term confidence in Walgreens Boots Alliance's recovery strategies.
Free Cash Flow Improvements
Another crucial aspect is the enhancement in the forecast for free cash flow (FCF) for FY25. It has shown significant improvement, now set at a negative $533 million rather than the previous estimate of negative $1.4 billion, signaling a healthier cash flow status.
Future EPS Growth Expectations
Experts shared insights indicating that with a projected recapture rate of 60%, the EPS growth for FY26 could remain nearly flat, paving the way for stronger earnings growth in FY27. This trajectory suggests a more optimistic long-term outlook for Walgreens Boots Alliance's financial wellness.
Quarterly Performance Highlights
In its fourth quarter of fiscal year 2024, Walgreens reported an adjusted EPS of $0.39, which exceeded expert expectations by 8.3%. For fiscal year 2025, the company anticipates its adjusted EPS to fall within a range of $1.40 to $1.80. The company has also announced plans to close around 1,200 underperforming stores over the next three years to optimize its operations.
Analyst Ratings and Targets
Several analyst firms, including Mizuho and Deutsche Bank, have reaffirmed their ratings for Walgreens Boots Alliance, setting varied price targets between $10 and $16. Conversely, BofA Securities retained its Underperform rating while establishing a lower price target of $7.50, citing ongoing challenges that persist despite efforts to cut costs.
InvestingPro Insights into Walgreens Boots Alliance
Insights from InvestingPro reassure the market positioning of Walgreens Boots Alliance (NASDAQ: WBA) despite facing difficulties. The company’s market capitalization is approximately $9.04 billion, and its revenue growth stands at 6.17% over the previous twelve months as of Q4 2024, indicating resilience.
However, Walgreens' finances still reveal mixed signals. The company's P/E ratio is currently negative at -2.59, reflecting heightened concerns regarding profitability, alongside a basic EPS of -$10.01 from continued operations during the same timeframe.
Furthermore, with a dividend yield of 9.57%, Walgreens might attract investors looking for income, though its dividend growth rate has seen a notable decline of 47.92% over the past year, sparking questions about the viability of sustaining such high yields.
Wrap-up
The revised insights into Walgreens Boots Alliance's earnings projections and cash flow estimates reinforce the complexity of its financial landscape. Investors are encouraged to stay abreast of future developments that may shape the company's long-term trajectory.
Frequently Asked Questions
What is the new price target for Walgreens Boots Alliance?
The new price target for Walgreens Boots Alliance has been lowered to $14 from the previous $16.
What is the adjusted EPS forecast for FY25?
The anticipated adjusted EPS for fiscal year 2025 is now $1.54, down from an earlier forecast of $1.71.
Are there any plans for store closures?
Yes, Walgreens plans to close around 1,200 underperforming stores over the next three years.
How did Walgreens fare in its latest earnings report?
Walgreens reported an adjusted EPS of $0.39 for Q4 FY24, surpassing estimates by 8.3%.
What is the future outlook for Walgreens Boots Alliance?
Analysts expect a potential return to growth in EPS by FY27, following a slower decline in FY26.
